Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Delve Bio Inc.

Headquarters: San Francisco, CA, United States of America
Year Founded: 2022
Status: Private

BioCentury | Oct 23, 2024
Discovery & Translation

Science Spotlight: Novo’s glucose-sensing insulin, two bacterial immunotherapies, and more

BioCentury’s roundup of translational innovations
BioCentury | Aug 28, 2023
Management Tracks

Kurt Graves takes top spot at i2o

Plus: Lourie Zak becomes CFO at Genelux, and updates from Delve Bio, Leo, and Synthetica
BioCentury | Jun 21, 2023
Deals

June 20 Quick Takes: FDA approves argenx’s subcutaneous Vyvgart

Plus: Clozel provides Idorsia cash lifeline, a clinical hold for Arcellx and updates from Vera, Denali, Delve Bio and Turbine
Items per page:
1 - 3 of 3
Help Center
Username
Request a Demo
Request Training
Ask a Question